These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2513307)

  • 1. Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation.
    Anwar H; Dasgupta M; Lam K; Costerton JW
    J Antimicrob Chemother; 1989 Nov; 24(5):647-55. PubMed ID: 2513307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.
    Anwar H; Strap JL; Chen K; Costerton JW
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1208-14. PubMed ID: 1416820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa.
    Anwar H; Costerton JW
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1666-71. PubMed ID: 2126686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of biofilm bacteria with antibiotics in a novel in vitro chemostat system.
    Anwar H; van Biesen T; Dasgupta M; Lam K; Costerton JW
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1824-6. PubMed ID: 2511804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material.
    Nickel JC; Ruseska I; Wright JB; Costerton JW
    Antimicrob Agents Chemother; 1985 Apr; 27(4):619-24. PubMed ID: 3923925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR; White A; Elborn JS; Tunney MM
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
    Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient exposure to a physiologically-relevant concentration of calcium confers tobramycin resistance upon sessile cells of Pseudomonas aeruginosa.
    Hoyle BD; Costerton JW
    FEMS Microbiol Lett; 1989 Aug; 51(3):339-41. PubMed ID: 2511067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth characteristics and expression of iron-regulated outer-membrane proteins of chemostat-grown biofilm cells of Pseudomonas aeruginosa.
    Anwar H; Strap JL; Costerton JW
    Can J Microbiol; 1991 Oct; 37(10):737-43. PubMed ID: 1777851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
    Koeva M; Gutu AD; Hebert W; Wager JD; Yonker LM; O'Toole GA; Ausubel FM; Moskowitz SM; Joseph-McCarthy D
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of biofilm cells of Staphylococcus aureus with tobramycin and cephalexin.
    Anwar H; Strap JL; Costerton JW
    Can J Microbiol; 1992 Jul; 38(7):618-25. PubMed ID: 1393831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
    Bilal H; Tait JR; Lang Y; Zhou J; Bergen PJ; Peleg AY; Bulitta JB; Oliver A; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0220321. PubMed ID: 35041509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
    Haagensen J; Verotta D; Huang L; Engel J; Spormann AM; Yang K
    J Antimicrob Chemother; 2017 Dec; 72(12):3357-3365. PubMed ID: 28961810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa.
    Oglesby-Sherrouse AG; Djapgne L; Nguyen AT; Vasil AI; Vasil ML
    Pathog Dis; 2014 Apr; 70(3):307-20. PubMed ID: 24436170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin.
    Coquet L; Junter GA; Jouenne T
    J Antimicrob Chemother; 1998 Dec; 42(6):755-60. PubMed ID: 10052899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of iron depletion on antimicrobial activities against planktonic and biofilm Pseudomonas aeruginosa.
    Cai Y; Yu XH; Wang R; An MM; Liang BB
    J Pharm Pharmacol; 2009 Sep; 61(9):1257-62. PubMed ID: 19703377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance of Pseudomonas aeruginosa colonizing a urinary catheter in vitro.
    Nickel JC; Wright JB; Ruseska I; Marrie TJ; Whitfield C; Costerton JW
    Eur J Clin Microbiol; 1985 Apr; 4(2):213-8. PubMed ID: 3924611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of tobramycin and polymyxin E against Pseudomonas aeruginosa biofilm-coated medical grade endotracheal tubes.
    Tarquinio K; Confreda K; Shurko J; LaPlante K
    Antimicrob Agents Chemother; 2014; 58(3):1723-9. PubMed ID: 24379207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.